These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8965734)

  • 1. [Pathological effects due to antineoplastic drugs in workers engaged in their production, preparation or administration].
    Merler E; Villa L; Lucchini R
    Med Lav; 1996; 87(3):207-21. PubMed ID: 8965734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytostatic drugs: occupational hazard to health care workers].
    Andrzejak R; Kucharski W; Mioduszewska J
    Med Pr; 1999; 50(1):61-5. PubMed ID: 10399719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk perception and self-assessment of exposure to antineoplastic agents in a group of nurses and pharmacists].
    Vollono C; Badoni G; Petrelli G
    G Ital Med Lav Ergon; 2002; 24(1):49-55. PubMed ID: 11892417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental and direct measures of exposure.
    Valanis B
    Occup Med; 1986; 1(3):431-44. PubMed ID: 3299787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for the health protection and safety of workers exposed to antineoplastic drugs].
    Palazzo S; Bernardo G; Draicchio F; Lucchini R; Merlano M; Minguzzi M; Molinaro V; Scanni A; Sossai D; Villa L
    Med Lav; 1996; 87(3):255-64. PubMed ID: 8965737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Documentation forms for monitoring occupational surveillance of healthcare workers who handle cytotoxic drugs.
    Parillo VL
    Oncol Nurs Forum; 1994; 21(1):115-20. PubMed ID: 8139995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Work practice and some adverse health effects in nurses handling antineoplastic drugs.
    Krstev S; Perunicić B; Vidaković A
    Med Lav; 2003; 94(5):432-9. PubMed ID: 14619181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The health surveillance of personnel who handle antineoplastic agents].
    Forni A; Alessio L; Cortona G; Erba P; Feltrin G; Pesatori A
    Med Lav; 1996; 87(3):265-7. PubMed ID: 8965738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes.
    Fransman W; Roeleveld N; Peelen S; de Kort W; Kromhout H; Heederik D
    Epidemiology; 2007 Jan; 18(1):112-9. PubMed ID: 17099323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to antineoplastic drugs outside the hospital environment.
    Meijster T; Fransman W; Veldhof R; Kromhout H
    Ann Occup Hyg; 2006 Oct; 50(7):657-64. PubMed ID: 16679337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Working and health conditions and preventive measures in a random sample of 5000 workers in the Veneto Region examined by telephone interview].
    Mastrangelo G; Perticaroli S; Camipo G; Priolo G; Leva A; de Merich D; Marangi G; Fedeli U; Fadda E; Scoizzato L; Marchiori L
    Med Lav; 2008; 99 Suppl 1():9-30. PubMed ID: 18404896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Summary of recommendations for a rational implementation of the ministry of health guidelines on the prevention of occupational risks in handling antineoplastic agents].
    Gruppo di Lavoro dell'Associazione Italiana di Medicina Preventiva dei Lavoratori della Sanità
    Med Lav; 2001; 92(2):137-48. PubMed ID: 11441591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biomonitoring of a population of nurses handling antineoplastic drugs.
    Cornetta T; Padua L; Testa A; Ievoli E; Festa F; Tranfo G; Baccelliere L; Cozzi R
    Mutat Res; 2008 Feb; 638(1-2):75-82. PubMed ID: 17928012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive hazards: an overview of exposures to health care workers.
    Shortridge-McCauley LA
    AAOHN J; 1995 Dec; 43(12):614-21. PubMed ID: 8694964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rules for prevention and certification of occupational diseases in workers occupationally exposed to antineoplastic drugs].
    Walusiak J; Wagrowska-Koski E; Pałczyński C
    Med Pr; 2001; 52(1):39-44. PubMed ID: 11424747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risks of using cytostatic drugs in veterinary medical practice].
    Pellicaan CH; Teske E
    Tijdschr Diergeneeskd; 1999 Apr; 124(7):210-5. PubMed ID: 10214684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is there an increase risk of cancer, reproduction complications and toxic events in workers exposed to antineoplastic agents?].
    Cañón-Montañez W; Rodríguez-Acelas AL
    Enferm Clin; 2010; 20(3):208-9. PubMed ID: 20452264
    [No Abstract]   [Full Text] [Related]  

  • 18. Policies and practices used for the safe handling of antineoplastic drugs.
    Wiseman KC; Wachs JE
    AAOHN J; 1990 Nov; 38(11):517-23. PubMed ID: 2242165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health effects of occupational exposure to cytostatics in medicinal personnel in the light of compulsory prophylactics: a cross-sectional study].
    Walusiak J; Wagrowska-Koski E; Pałczyński C
    Med Pr; 2003; 54(3):229-36. PubMed ID: 14669575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The handling of antineoplastic drugs in a major cancer center.
    Hoffman DM
    Hosp Pharm; 1980 Jun; 15(6):302-4. PubMed ID: 10247269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.